ALBI (Albumin-Bilirubin) Grade for Hepatocellular Carcinoma (HCC)

ورودی‌های بالینی بیمار

حداقل ۱۰ — حداکثر ۶۰ • واحد: g/L

حداقل ۱ — حداکثر ۱۰۰۰ • واحد: μmol/L

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
albi score
—score
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Grade 1-10–-2.6
  • Grade 2-2.6–-1.39
  • Grade 3-1.39–10
Direct Clinical Answer

The ALBI (Albumin-Bilirubin) Grade for Hepatocellular Carcinoma (HCC) calculates predicting survival in hepatocellular carcinoma patients based on objective measures of liver function (albumin and bilirubin). Key inputs include albumin. Scores guide adjusting systemic antineoplastic regimens, planning supportive palliative measures, or targeted monitoring. Routine clinical application promotes standardized evidence-based patient management.

Clinical Guidelines & Evidence

Predicts survival in hepatocellular carcinoma patients based on objective measures of liver function (albumin and bilirubin)

Clinical Indication

The ALBI (Albumin-Bilirubin) Grade for Hepatocellular Carcinoma (HCC) is indicated for bedside clinical practice to support Predicts survival in hepatocellular carcinoma patients based on objective measures of liver function (albumin and bilirubin). It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients with solid tumors or hematologic malignancies undergoing staging, systemic therapy tolerability assessment, or prognostic stratification. Clinical application is indicated across Medical oncology clinics, chemotherapy infusion suites, inpatient oncology services, and palliative care.

Limitations & Contraindications

Prognostic indices provide statistical cohort survival estimates and must not replace individualized patient goals of care.

Clinical Pearls & Action Plan

Standardized functional performance status (ECOG or Karnofsky) is an independent determinant of chemotherapy tolerance and survival. Guideline pearl: Useful for treatment selection and prognostication.

Formula & Variables:

ALBI = (log10 bilirubin × 0.66) + (albumin × -0.085), where bilirubin is in μmol/L and albumin in g/L

Input Parameters

NameTypeRequiredDescription
albuminfloatYesSerum albumin level in g/L(g/L)
bilirubinfloatYesSerum bilirubin level in μmol/L(μmol/L)

Score Interpretation & Guidance

RangeStageDescription
-10–-2.6Grade 1Best liver function
-2.6–-1.39Grade 2Intermediate liver function
-1.39–10Grade 3Poor liver function

Evidence-Based References (EBM)

  • Johnson PJ, Berhane S, Kagebayashi C, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J Clin Oncol. 2015;33(6):550-8.
  • Hiraoka A, Michitaka K, Kumada T, et al. Validation and Potential of Albumin-Bilirubin Grade and Prognostication in a Nationwide Survey of 46,681 Hepatocellular Carcinoma Patients in Japan: The Need for a More Detailed Evaluation of Hepatic Function. Liver Cancer. 2017;6(4):325-336.
  • Chen B, Lin S. Albumin-bilirubin (ALBI) score at admission predicts possible outcomes in patients with acute-on-chronic liver failure. Medicine (Baltimore). 2017;96(24):e7142.

Related calculators